Liraglutide (TFA) is an agonist of the glucagon-like peptide 1 receptor (GLP-1). It activates GLP-1, leading to insulin secretion when glucose levels are elevated. Additionally, Liraglutide (TFA) reduces glucagon secretion in a glucose-dependent manner. This compound is utilized in research related to type 2 diabetes.
Target-Kategorie:
Glucagon Receptor
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
